Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study

To our best knowledge, this was the first study to address the efficacy of the mHealth app m-RESIST on the symptoms and functional capacity and on the quality of life for people with TRS. Our preliminary findings showed that implementing the m-RESIST solution decreased the symptoms and severity of disease, and improved the functionality and perceived quality of life among those with TRS. The change of symptoms on the PANSS total may be clinically significant. Modern technologies such as mHealth interventions may be useful in treating symptoms and functionality even in TRS, which is a major clinical challenge, with usually poor outcomes. These results should be corroborated by performing a controlled trial.

Authors

Institutions

Publication Details

Journal
JMIR Human Factors
Published
2025-03-27
DOI
https://doi.org/10.2196/67659
Primary Topic
Digital Mental Health Interventions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study

Judith Usall, Katya Rubinstein, Zsolt Unoka, Jesús Berdún et al.
2 links
JMIR Human Factors
Digital Mental Health Interventions
article

Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study

Judith Usall, Katya Rubinstein, Zsolt Unoka, Jesús Berdún, Susana Ochoa, Alexandra Roldán, Cari Almazán, Marianne Haapea, Asaf Caspi, Erika Jääskeläinen, Kinga Farkas, Anna Alonso-Solís, Iluminada Corripio, Jussi Seppälä, Johanna Caro Mendivelso, Eva Grasa, Jouko Miettunen, Elisenda Reixach, Matti Isohanni
article en

Abstract

To our best knowledge, this was the first study to address the efficacy of the mHealth app m-RESIST on the symptoms and functional capacity and on the quality of life for people with TRS. Our preliminary findings showed that implementing the m-RESIST solution decreased the symptoms and severity of disease, and improved the functionality and perceived quality of life among those with TRS. The change of symptoms on the PANSS total may be clinically significant. Modern technologies such as mHealth interventions may be useful in treating symptoms and functionality even in TRS, which is a major clinical challenge, with usually poor outcomes. These results should be corroborated by performing a controlled trial.

JMIR Human FactorsVol. 12
Semmelweis University (HU), Generalitat de Catalunya (ES), Oulu University Hospital (FI), Social Insurance Institution (FI), Sheba Medical Center (IL), Hospital de Sant Pau (ES), Centro de Investigación Biomédica en Red de Salud Mental (ES), Althaia (ES), Agència de Qualitat i Avaluació Sanitàries de Catalunya (ES), Parc Sanitari Sant Joan de Déu (ES), University of Oulu (FI)
Centres de Recerca de Catalunya, European Commission, Generalitat de Catalunya, Horizon 2020 Framework Programme
Openalex Percentile: Top 94%
Digital Mental Health Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.